A novel form of complete IL-12/IL-23 receptor β1 deficiency with cell surface-expressed nonfunctional receptors

Blood

Volumn 104, Issue 7, 2004, Pages 2095-2101

  Fieschi, Claire ^b   Bosticardo, Marita ^b   De Beaucoudrey, Ludovic ^b   Boisson Dupuis, Stéphanie ^b   Feinberg, Jacqueline ^b   Santos, Orchidée Filipe ^b   Bustamante, Jacinta ^b   Levy, Jacov ^b   Candotti, Fabio ^b   Casanova, Jean Laurent ^a  

^a INSERM   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 12 BETA1 RECEPTOR ANTIBODY; INTERLEUKIN 12 RECEPTOR; INTERLEUKIN 23 BETA1 RECEPTOR; INTERLEUKIN RECEPTOR; MONOCLONAL ANTIBODY; NUCLEOTIDE; STAT4 PROTEIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CASE REPORT; CYTOKINE PRODUCTION; EXON; GENE DELETION; GENE MUTATION; GENE TRANSFER; HUMAN; HUMAN CELL; INFECTION SENSITIVITY; MALE; MYCOBACTERIOSIS; NATURAL KILLER CELL; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; RECEPTOR DENSITY; RECEPTOR INTRINSIC ACTIVITY; SALMONELLOSIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 4644310307     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-02-0584     Document Type: Article

References (44)

1. Casanova JL, Abel L. Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol. 2002;20:581-620.
2. Dorman SE, Holland SM. Interferon-gamma and interleukin-12 pathway defects and human disease. Cytokine Growth Factor Rev. 2000;11:321-333.
3. Jouanguy E, Döftinger R, Dupuis S, Pallier A, Altare F, Casanova JL. IL-12 and IFN-γ in host defense against mycobacteria and salmonella in mice and men. Curr Opin Immunol. 1999;11:346-351.
4. Jouanguy E, Lamhamedi-Cherradi S, Lammas D, et al. A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection. Nat Genet. 1999;21:370-378.
5. Dupuis S, Dargemont C, Fieschi C, et al. Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation. Science. 2001;293:300-303.
6. Frucht DM, Sandberg DI, Brown MR, Gerstberger SM, Holland SM. IL-12-independentcostimulation pathways for interferon-γ production in familial disseminated Mycobacterium avium complex infection. Clin Immunol. 1999;91:234-241.
7. Jouanguy E, Altare F, Lamhamedi S, et al. Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection. N Engl J Med. 1996;335:1956-1961.
8. Newport MJ, Huxley CM, Huston S, et al. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N Engl J Med. 1996;335:1941-1949.
9. Jouanguy E, Dupuis S, Pallier A, et al. In a novel form of IFN-gamma receptor 1 deficiency, cell surface receptors fail to bind IFN-gamma. J Clin Invest. 2000;105:1429-1436.
10. Allende LM, Lopez-Goyanes A, Paz-Artal E, et al. A point mutation in a domain of gamma interferon receptor 1 provokes severe immunodeficiency. Clin Diagn Lab Immunol. 2001;8:133-137.
11. Jouanguy E, Lamhamedi-Cherradi S, Altare F, et al. Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guerin infection and a sibling with clinical tuberculosis. J Clin Invest. 1997;100:2658-2664.
12. Dorman SE, Holland SM. Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection. J Clin Invest. 1998;101:2364-2369.
13. Döffinger R, Jouanguy E, Dupuis S, et al. Partial interferon gamma receptor signaling chain deficiency in a patient with bacille Calmette-Guérin and Mycobacterium abscessus infection. J Infect Dis. 2000;181:379-384.
14. Dupuis S, Jouanguy E, Al-Hajjar S, et al. Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency. Nat Genet. 2003;33:388-391.
15. Altare F, Lammas D, Revy P et al. Inherited interleukin 12 deficiency in a child with bacille Calmette-Guérin and Salmonella enteritidis disseminated infection. J Clin Invest. 1998;102:2035-2040.
16. Picard C, Fieschi C, Altare F, et al. Inherited interleukin-12 deficiency: IL12B genotype and clinical phenotype of 13 patients from six kindreds. Am J Hum Genet. 2002;70:336-348.
17. Elloumi-Zghal H, Barbouche MR, Chemli J, et al. Clinical and genetic heterogeneity of inherited autosomal recessive susceptibility to disseminated Mycobaclerium bovis bacille calmette-guerin infection. J Infect Dis. 2002;185:1468-1475.
18. Altare F, Durandy A, Lammas D, et al. Impairment of mycobacterial immunity in human interteukin-12 receptor deficiency. Science. 1998;280:1432-1435.
19. de Jong R, Altare F, Haagen IA, et al. Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science. 1998;280:1435-1438.
20. Verhagen CE, de Boer T, Smits HH, et al. Residual type 1 immunity in patients genetically deficient for interleukin 12 receptor beta1 (IL-12Rbeta1): evidence for an IL-12Rbeta1-independent pathway of IL-12 responsiveness in human T cells. J Exp Med. 2000;192:517-528.
21. Aksu G, Tirpan C, Cavusoglu C, et al. Mycobacterium fortuitum-chelonae complex infection in a child with complete interleukin-12 receptor beta 1 deficiency. Pediatr Infect Dis J. 2001;20:551-553.
22. Altare F, Ensser A, Breiman A, et al. Interteukin-12 receptor beta1 deficiency in a patient with abdominal tuberculosis. J Infect Dis. 2001;184:231-236.
23. Sakai T, Matsuoka M, Aoki M, Nosaka K, Mitsuya H. Missense mutation of the interleukin-12 receptor beta1 chain-encoding gene is associated with impaired immunity against Mycobacterium avium complex infection. Blood. 2001;97:2688-2694.
24. Lichtenauer-Kaligis EG, De Boer T, Verreck FA, et al. Severe Mycobacterium bovis BCG infections in a large series of novel IL-12 receptor beta1 deficient patients and evidence for the existence of partial IL-12 receptor beta1 deficiency. Eur J Immunol. 2003;33:59-69.
25. Cleary AM, Tu W, Enright A, et al. Impaired accumulation and function of memory CD4 T cells in human IL-12 receptor beta1 deficiency. J Immunol. 2003;170:597-603.
26. Fieschi C, Dupuis S, Catherinot E, et al. Low penetrance, broad resistance, and favorable outcome of interleukin 12 receptor beta1 deficiency: medical and immunological implications. J Exp Med. 2003;197:527-535.
27. Staretz-Haham O, Melamed R, Ushitz M, et al. IL 12 receptor beta1 deficiency presenting as recurrent Salmonella infection. Clin Infect Dis. 2003;37:137-140.
28. Caragol I, Raspall M, Fieschi C, et al. Clinical tuberculosis in two of three siblings with interteukin-12 receptor beta1 deficiency. Clin Infect Dis. 2003;37:302-306.
29. Fieschi C, Casanova JL. The role of interleukin-12 in human infectious diseases: only a faint signature. Eur J Immunol. 2003;33:1461-1464.
30. Casanova JL, Abel L. The human model: a genetic dissection of immunity to infection in natural conditions. Nat Rev Immunol. 2004;4:55-66.
31. Uzel G, Frucht DM, Fleisher TA, Holland SM. Detection of intracellular phosphorylated STAT-4 by flow cytometty. Clin Immunol. 2001;100:270-276.
32. Miller AD, Garcia JV, von Suhr N, Lynch CM, Wilson C, Eiden MV. Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus. J Virol. 1991;65:2220-2224.
33. Candotti F, Johnston JA, Puck JM, Sugamura K, O'Shea JJ, Blaese RM. Retroviral-mediated gene correction for X-linked severe combined immunodeficiency. Blood. 1996;87:3097-3102.
34. den Dunnen JT, Antonarakis SE. Nomenclature for the description of human sequence variations. Hum Genet. 2001;109:121-124.
35. Kaplan MH, Sun YL, Hoey T, Grusby MJ. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature. 1996;382:174-177.
36. Thierfelder WE, van Deursen JM, Yamamoto K, et al. Requirements for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature. 1996;382:171-174.
37. Oppmann B, Lesley R, Blom B, et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity. 2000;13:715-725.
38. Parham C, Chirica M, Timans J, et al. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J Immunol. 2002;168:5699-5708.
39. Trinchieri G. Interteukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol. 2003;3:133-146.
40. Hoeve MA, de Boer T, Langenberg DM, Sanal O, Verreck FA, Ottenhoff TH. IL-12 receptor deficiency revisited: IL-23-mediated signaling is also impaired in human genetic IL-12 receptor beta1 deficiency. Eur J Immunol. 2003;33:3393-3397.
41. Boulay JL, O'Shea JJ, Paul WE. Molecular phylogeny within type I cytokines and their cognate receptors. Immunity. 2003;19:159-163.
42. Bravo J, Heath JK. Receptor recognition by gp130 cytokines. EMBO J. 2000;19:2399-2411.
43. Bravo J, Staunton D, Heath JK, Jones EY. Crystal structure of a cytokine-binding region of gp130. EMBO J. 1998;17:1665-1674.
44. Horsten U, Schmitz-Van de Leur H, Mullberg J, Heinrich PC, Rose-John S. The membrane distal half of gp130 is responsible for the formation of a ternary complex with IL-6 and the IL-6 receptor. FEBS Lett. 1995;360:43-46.